These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 32359481)

  • 1. Transcription Factor Inhibition: Lessons Learned and Emerging Targets.
    Chen A; Koehler AN
    Trends Mol Med; 2020 May; 26(5):508-518. PubMed ID: 32359481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcription factors and chromatin proteins as therapeutic targets in cancer.
    Johnston SJ; Carroll JS
    Biochim Biophys Acta; 2015 Apr; 1855(2):183-92. PubMed ID: 25721328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting acute myeloid leukemia with a small molecule inhibitor of the Myb/p300 interaction.
    Uttarkar S; Dassé E; Coulibaly A; Steinmann S; Jakobs A; Schomburg C; Trentmann A; Jose J; Schlenke P; Berdel WE; Schmidt TJ; Müller-Tidow C; Frampton J; Klempnauer KH
    Blood; 2016 Mar; 127(9):1173-82. PubMed ID: 26631113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small-molecule inhibitors of Wnt signaling pathway: towards novel anticancer therapeutics.
    Zheng S; Liu J; Wu Y; Huang TL; Wang G
    Future Med Chem; 2015; 7(18):2485-505. PubMed ID: 26670195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stabilization of the Max Homodimer with a Small Molecule Attenuates Myc-Driven Transcription.
    Struntz NB; Chen A; Deutzmann A; Wilson RM; Stefan E; Evans HL; Ramirez MA; Liang T; Caballero F; Wildschut MHE; Neel DV; Freeman DB; Pop MS; McConkey M; Muller S; Curtin BH; Tseng H; Frombach KR; Butty VL; Levine SS; Feau C; Elmiligy S; Hong JA; Lewis TA; Vetere A; Clemons PA; Malstrom SE; Ebert BL; Lin CY; Felsher DW; Koehler AN
    Cell Chem Biol; 2019 May; 26(5):711-723.e14. PubMed ID: 30880155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small-molecule inhibitors of breast cancer-related targets: Potential therapeutic agents for breast cancer.
    Liu T; Song S; Wang X; Hao J
    Eur J Med Chem; 2021 Jan; 210():112954. PubMed ID: 33158576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A historical overview of protein kinases and their targeted small molecule inhibitors.
    Roskoski R
    Pharmacol Res; 2015 Oct; 100():1-23. PubMed ID: 26207888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel activators and small-molecule inhibitors of STAT3 in cancer.
    Yang L; Lin S; Xu L; Lin J; Zhao C; Huang X
    Cytokine Growth Factor Rev; 2019 Oct; 49():10-22. PubMed ID: 31677966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perspectives of small molecule inhibitors of activin receptor‑like kinase in anti‑tumor treatment and stem cell differentiation (Review).
    Cui X; Shang S; Lv X; Zhao J; Qi Y; Liu Z
    Mol Med Rep; 2019 Jun; 19(6):5053-5062. PubMed ID: 31059090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovering small molecules as Wnt inhibitors that promote heart regeneration and injury repair.
    Xie S; Fu W; Yu G; Hu X; Lai KS; Peng X; Zhou Y; Zhu X; Christov P; Sawyer L; Ni TT; Sulikowski GA; Yang Z; Lee E; Zeng C; Wang WE; Zhong TP
    J Mol Cell Biol; 2020 Jan; 12(1):42-54. PubMed ID: 30925593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small-molecule inhibitors of c-Myc transcriptional factor suppress proliferation and induce apoptosis of promyelocytic leukemia cell via cell cycle arrest.
    Jeong KC; Ahn KO; Yang CH
    Mol Biosyst; 2010 Aug; 6(8):1503-9. PubMed ID: 20485733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Taming the Notch Transcriptional Regulator for Cancer Therapy.
    Tamagnone L; Zacchigna S; Rehman M
    Molecules; 2018 Feb; 23(2):. PubMed ID: 29462871
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacological disruption of the Notch transcription factor complex.
    Lehal R; Zaric J; Vigolo M; Urech C; Frismantas V; Zangger N; Cao L; Berger A; Chicote I; Loubéry S; Choi SH; Koch U; Blacklow SC; Palmer HG; Bornhauser B; González-Gaitán M; Arsenijevic Y; Zoete V; Aster JC; Bourquin JP; Radtke F
    Proc Natl Acad Sci U S A; 2020 Jul; 117(28):16292-16301. PubMed ID: 32601208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. c-MYB and DMTF1 in Cancer.
    Fry EA; Inoue K
    Cancer Invest; 2019; 37(1):46-65. PubMed ID: 30599775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA-binding small molecules as inhibitors of transcription factors.
    Leung CH; Chan DS; Ma VP; Ma DL
    Med Res Rev; 2013 Jul; 33(4):823-46. PubMed ID: 22549740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overlapping activities of TGF-β and Hedgehog signaling in cancer: therapeutic targets for cancer treatment.
    Perrot CY; Javelaud D; Mauviel A
    Pharmacol Ther; 2013 Feb; 137(2):183-99. PubMed ID: 23063491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the transcription factor Myb by small-molecule inhibitors.
    Uttarkar S; Frampton J; Klempnauer KH
    Exp Hematol; 2017 Mar; 47():31-35. PubMed ID: 28017646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small-molecule inhibitors of linear ubiquitin chain assembly complex (LUBAC), HOIPINs, suppress NF-κB signaling.
    Katsuya K; Oikawa D; Iio K; Obika S; Hori Y; Urashima T; Ayukawa K; Tokunaga F
    Biochem Biophys Res Commun; 2019 Feb; 509(3):700-706. PubMed ID: 30611571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of novel pathways and molecules able to down-regulate PHOX2B gene expression by in vitro drug screening approaches in neuroblastoma cells.
    Di Zanni E; Fornasari D; Ravazzolo R; Ceccherini I; Bachetti T
    Exp Cell Res; 2015 Aug; 336(1):43-57. PubMed ID: 25882494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small molecules to the rescue: Inhibition of cytokine signaling in immune-mediated diseases.
    Gadina M; Gazaniga N; Vian L; Furumoto Y
    J Autoimmun; 2017 Dec; 85():20-31. PubMed ID: 28676205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.